Please provide your email address to receive an email when new articles are posted on . Impulse Dynamics announced that a two-lead version of its implantable pulse ...
The U.S. Food and Drug Administration’s (FDA) advisory committee has voted to recommend an innovative pacemaker-style gadget be approved in the United States. Created by German company Impulse ...
DUBLIN--(BUSINESS WIRE)--The "Implantable Pulse Generator Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering. Implantable pulse generator market is ...
Neuronoff, Inc., a clinical-stage neuromodulation company, today announced successful chronic large animal demonstration of ...
Inspire Medical Systems Inc. (INSP) has issued a recall of its Inspire IV Implantable Pulse Generator (IPG) Model 3028 due to a critical manufacturing defect. The FDA has classified this as the most ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...
We are determining the anatomical characteristics, simulation, design and test development of an Implantable Pulse Generator (IPG). Our project goal is to determine the lead pathway for the electrode ...
Inspire Medical Systems has issued a recall for the Inspire IV Implantable Pulse Generator (IPG) Model 3028 because of a manufacturing defect that could disrupt therapy and cause serious adverse ...
An advisory panel of the US Food and Drug Administration yesterday voted 12-0, with one abstention, that the benefits of cardiac contractility modulation (CCM) therapy with an implantable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results